articleTop 1% cited
Outcomes of patients with multiple myeloma refractory to CD38-targeted monoclonal antibody therapy
Leukemia · 2019 · Vol. 33(9) · pp. 2266–2275
Ujjawal H. Gandhi✉(Vanderbilt University Medical Center)Robert F. Cornell(Vanderbilt University Medical Center)Arjun Lakshman(Mayo Clinic in Arizona)Zhubin Gahvari(University of Wisconsin–Madison)Elizabeth McGehee(The University of Texas Southwestern Medical Center)Megan H. Jagosky(Carolinas Healthcare System)Ridhi Gupta(Cancer Prevention Institute of California)William Varnado(University of Alabama at Birmingham)Mark A. Fiala(Washington University in St. Louis)Saurabh Chhabra(Medical College of Wisconsin)Ehsan Malek(University Hospitals Seidman Cancer Center)Joshua Mansour(Medical University of South Carolina)Barry Paul(Duke University)Alyssa Barnstead(Oregon Health & Science University)Saranya Kodali(University of Vermont)Amarendra Kumar Neppalli(Medical University of South Carolina)Michaela Liedtke(Cancer Prevention Institute of California)Swapna Narayana(Medical College of Wisconsin)Kelly Godby(University of Alabama at Birmingham)Yubin Kang(Duke University)Ankit Kansagra(The University of Texas Southwestern Medical Center)Elvira Umyarova(University of Vermont)Emma C. Scott(Oregon Health & Science University)Parameswaran Hari(Medical College of Wisconsin)Ravi Vij(Washington University in St. Louis)Saad Z. Usmani(Carolinas Healthcare System)Natalie S. Callander(University of Wisconsin–Madison)Shaji Kumar(Mayo Clinic in Arizona)Luciano J. Costa(University of Alabama at Birmingham)
Multiple Myeloma Research and TreatmentsPeptidase Inhibition and AnalysisCancer therapeutics and mechanismsDaratumumabCarfilzomibMedicineRefractory (planetary science)Internal medicineRegimenPopulationCD38LenalidomideMultiple myeloma
MeSH terms
Antineoplastic Agents, ImmunologicalProgression-Free SurvivalAdultAgedAged, 80 and overAntibodies, MonoclonalAntineoplastic Combined Chemotherapy ProtocolsFemaleHumansImmunologic FactorsImmunotherapyMaleMembrane GlycoproteinsMiddle AgedMultiple Myeloma
Funding
- Vanderbilt University Medical Center
Citations
603
FWCI
45.81
field-weighted impact
References
27
Percentile
100%
vs. same field & year
Citations per year
Cited by
Understanding constraints in adopting recommended paddy cultivation practices: Insights from farmer producer organization (FPO) members and non-members in Andhra Pradesh
International Journal of Agriculture Extension and Social Development · 2024 · 0 citations
References
Multiple Myeloma: Diagnosis and Treatment
Mayo Clinic Proceedings · 2016 · 806 citations
Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients
Leukemia · 2013 · 1,380 citations
International uniform response criteria for multiple myeloma
Leukemia · 2006 · 2,623 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.